Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

25.60
+0.26001.03%
Volume:143.12K
Turnover:3.47M
Market Cap:41.94M
PE:- -
High:25.70
Open:24.10
Low:22.71
Close:25.34
52wk High:152.22
52wk Low:11.52
Shares:1.64M
Float Shares:1.64M
Volume Ratio:0.80
T/O Rate:8.74%
Dividend:3.85
Dividend Rate:15.03%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

tempus AI Inc Class A call volume above normal and directionally bullish

TIPRANKS
·
Aug 19

Tempus AI Director Nadja West Disposes of 3,000 Common Shares Worth $161,700

Reuters
·
Aug 19

30-Year Treasury Yield Hits 5.31%: The Triple Squeeze Of Oil, Deficits And AI Debt

Macro World​
·
Aug 18

BofA's Hartnett: The 2026 Midterms Will Decide It — AI Bull Market Either Melts Up Into 2027, Or Drops More Than 10%

AI Industry Frontlines
·
Aug 14

Is The Token No Longer The Yardstick? OpenAI And Anthropic Are Rewriting The Rules For Premium AI

AI Industry Frontlines
·
Aug 14

AI Software Shares Jump. AppLovin, Cloudflare up Around 4%; Palantir up over 3%; Trade Desk, Datadog, Shopify, Duolingo up over 2%

Tiger Newspress
·
Aug 13

Tempus AI CEO Data Ryan Fukushima Disposes of 20.000 Shares Worth $1 Juta

Reuters
·
Aug 12

AI Software Shares Rise. Tempus AI up 7%; Datadag up Nearly 5%; Spotify, Duolingo, Braze up over 4%; Roblox, Snowflake, Figma up over 2%

Tiger Newspress
·
Aug 10

Tempus AI (TEM) After CellCarta Deal And PRISM2 Validation Faces A Fresh Valuation Test

Simply Wall St.
·
Aug 10

Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network

Simply Wall St.
·
Aug 08

Cellcarta: Adds Tempus to Cdx Commercialization Lab Network as Second Commercial Lab Partner

THOMSON REUTERS
·
Aug 06

Tempus AI CEO, Data Ryan Fukushima Reports Disposal of 23,818 Common Shares Worth $1.1 Million

Reuters
·
Aug 06

Tempus AI announces study results of PRISM2

TIPRANKS
·
Aug 04

Tempus AI Inc : Btig Cuts Target Price to $70 from $80

THOMSON REUTERS
·
Aug 04

JPMorgan: The AI Trade Won't Lead the Market in the Second Half

Analyst Calls
·
Aug 04

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Aug 04

Tempus AI price target lowered to $56 from $64 at H.C. Wainwright

TIPRANKS
·
Aug 04

Tempus AI is Maintained at Hold by Stifel

Dow Jones
·
Aug 03

Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains

TIPRANKS
·
Aug 01

Tempus AI Price Target Maintained with a $75.00/Share by Needham

Dow Jones
·
Jul 31